Drug ID: | NPD238 |
Drug Name: | |
Molecular Formula: | C10H13FN2O4 |
Canonical SMILES: | OCC1OC(CC1[18F])n1cc(C)c(nc1=O)O |
Standard InCHI: | InChI=1S/C10H13FN2O4/c1-5-3-13(10(16)12-9(5)15)8-2-6(11)7(4-14)17-8/h3,6-8,14H,2,4H2,1H3,(H,12,15,16)/i11-1 |
Standard InCHIKey: | UXCAQJAQSWSNPQ-KXMUYVCJSA-N |
Max Developmental Stage: | Clinical (unspecified phase) |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNCL002601 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 450772 |
ChEBI | |
CAS Number |
Molecular Weight | 244.09 |
ALogP | -0.8307 |
MLogP | 1.79 |
XLogP | -0.255 |
HDA | 6 |
HBD | 2 |
Rotatable Bonds | 6 |
TPSA | 82.36 |
RO5 Violation | 0 |